Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 37, 2005 - Issue 1
Submit an article Journal homepage
97
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh

Khalequ Zaman From the ICDDR,B: Centre for Health and Population Research, DhakaCorrespondence[email protected]
,
Zeaur Rahim From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Mohammad Yunus From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Shams E. Arifeen From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Abdullah H. Baqui Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
,
David A. Sack From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Shahed Hossain From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Sayera Banu From the ICDDR,B: Centre for Health and Population Research, Dhaka
,
Mohammad Akramul Islam Bangladesh Rural Advancement Committee (BRAC), Mohakhali, Dhaka, Bangladesh
,
Jalaluddin Ahmed National Tuberculosis Control Programme (NTP), DGHS, Mohakhali, Dhaka, Bangladesh
,
Robert F. Breiman From the ICDDR,B: Centre for Health and Population Research, Dhaka
&
Robert E. Black Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
 show all
Pages 21-26 | Received 27 Jul 2004, Accepted 20 Oct 2004, Published online: 08 Jul 2009

References

  • Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the US, 1993–1996. JAMA 1997;278:833–7.
  • Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis drug resistance, 1994–1997. N Engl J Med 1998;338: 1641–9.
  • Espinal MA, Baez J, Soriano G, Garcia V, Laszlo A, Reingold AL, Sanchez S. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int J Tuberc Lung Dis 1998;2:490–8.
  • World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project of anti-tuberculosis drug resistance surveillance. World Health Organization, Geneva, Switzerland, 1997, WHO/TB/97.289.
  • Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr. Multidrug- resistant tuberculosis [editorial]. Ann Intern Med 1992;117:257–9.
  • Rattan A, Kalia A, Ahmed N. Multidrug-resistantMycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998;4:195–209.
  • Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali E, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001;5:887–93.
  • Farmer P, Bayona J, Becerra M. Multidrug resistant tuberculosis and the need for biosocial perspectives. Int J Tuberc Lung Dis 2001;5:885–6.
  • World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2003. Geneva, Switzerland, WHO/CDS/TB/2003.316.
  • World Health Organization. Tuberculosis Control in the southeast Asia region: The regional report 2003: World Health Organization 2003, New Delhi, India, SEA/TB/260.
  • International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). HIV surveillance in Bangladesh. Health and Science Bulletin 2003;1:1–7.
  • Deun AV, Aung KJM, Chowdhury S, Saha S, Pankaj A, Ashraf A, et al. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Int J Tuberc Lung Dis 1999;3:143–8.
  • Hossain MR, Ali MS, Alam MN, Haq SA, Amin MR, Ali AKMA, et al. Primary drug resistance pattern of M. tuberculosis: report of 101 cases. In: Abstract 20th Annual General Meeting and Scientific Seminar. The Chest and Heart Association of Bangladesh, 1998.
  • International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Demographic Surveillance System: Matlab Vol. 1, methods and procedures. ICDDR,B Sci Rep 9, 1978.
  • Bhatia S, Mosley WH, Faruque ASG, Chakraborty J. The Matlab Family Planning Health Services Project. Stud Fam Plan 1980;11:202–12.
  • Petroff SA. A new and rapid method for the isolation and culture of tubercle bacilli directly from the sputum and faeces. J Exp Med 1915;21:38–42.
  • Canetti G, Fox W, Khomenco A, Mahlar HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969;41: 21–43.
  • World Health Organization. Treatment of tuberculosis: Guidelines for national programmes. WHO 2003, Geneva, Switzerland, WHO/CDS/TB/2003.313.
  • World Health Organization. Guidelines for the management of drug-resistant tuberculosis. WHO, Geneva, Switzerland, WHO/TB/96.210 (Rev.1) 1998.
  • Kruuner A, Sillastu H, Danilovitsh M, Levina K, Svenson SB, Kallenius G, Hoffner E. Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis 1998;2:130–3.
  • Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Eng J Med 1993;328: 521–6.
  • Githui WA, Juma ES, van Gorkom J, Kibuga D, Odhiambo J, Drobniewski F. Anti-tuberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis 1998;2:499–505.
  • Lambregts-van Weezenbeek CSB, Jansen HM, Nagelkerke NJD, van Klingeren B, Veen J. Nationwide surveillance of drug-resistant tuberculosis in the Netherlands: rates, risk factors and treatment outcome. Int J Tuberc Lung Dis 1998;2:288–95.
  • Nutini S, Tortoli E, Corrado A. Multidrug-resistant tuberculosis in the Florence province from to 1992 to 1995. Int J Tuberc Lung Dis 1998;2: 484–9.
  • Varaiya A, Gogate A. Drug resistance to the first line of antitubercular regimen (a preliminary report). Ind J Pub Hlth 1998;42:126–30.
  • Heymann SJ, Brewer TF, Wilson ME, Fineberg HV. The need for global action against multidrug-resistant tuberculosis. JAMA 1999;281:2138–40.
  • Farmer P, Yong Kim J. Community based approaches to the control of multidrug resistant tuberculosis: introducing ‘DOTS-plus’. Br MedJ 1998;317:671–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.